- AyurVAID Pharmacy
Hours of Operation:
8am – 8pm (Mon-Sat)
8am – 5pm (Sun)
Hours of Operation:
8am – 8pm (Mon-Sat)
8am – 5pm (Sun)
Dementia India Alliance (DIA), a national, NGO dedicated to promoting awareness, advocacy, and care for people living with dementia, and Apollo AyurVAID Hospitals, India’s leading Precision Ayurveda hospital network under the Apollo Hospitals Group, have joined hands to advance integrative dementia care and awareness in India.
The collaboration aims to address the growing public health challenge posed by dementia by combining DIA’s expertise in care, community engagement and advocacy with Apollo AyurVAID’s clinical leadership in precision Ayurveda and integrative medicine. Together, the two organisations will work towards creating awareness that encourages timely medical help, facilitates early diagnosis, and better management of the condition.
With India’s elderly population expected to reach 319 million by 2050, accounting for one-fifth of the total population, the country faces a mounting public health challenge. According to industry estimates, about 7.4 per cent of Indians aged 60 and above are affected by dementia which is nearly 88 lakh people today – a number projected to rise to 1.7 crore by 2036.
Early and accurate diagnosis is the cornerstone of effective care, yet nearly 90 per cent of those living with dementia in India remain undiagnosed due to the limited availability of memory clinics, a critical gap that must be bridged to enable timely intervention and support. The increasing prevalence of risk factors associated with dementia — such as diabetes, hypertension, and more than 14 other modifiable factors — underscores the urgent need for proactive risk reduction and early intervention strategies.
Apollo Hospitals’ Ayurveda arm, AyurVaid, is set for major expansion with plans to open four new hospitals within the next three months. This move will increase its network to 16 hospitals with over 350 beds, reflecting the growing interest in Ayurveda, especially among younger patients, according to a senior company executive.
Healthcare major Apollo Hospitals is planning to add four new facilities to its precision ayurveda healthcare arm, Apollo AyurVAID Hospitals, expanding the network to 350 beds over the next three to four months. The move comes as the group bets on the country’s growing demand for ayurveda-based in-patient and out-patient care.
Apollo AyurVAID Hospitals on Monday opened a 35-bed facility in Chennai. “We will not stop with one or two centres. We are trying to create a network that is fully integrated with the Apollo ecosystem. It will also be open to any healthcare provider that meets our standards of quality and care,” said Preetha Reddy, executive vice chairperson, Apollo Hospitals Enterprise, and chairperson, Apollo AyurVAID.
Apollo AyurVAID Hospi- tals, the Apollo Hospitals Group’s chain of precision Ayurveda hospitals, inaug- urated its flagship 35-bed facility on Greams Road on Monday. The centre, which was inaugurated by Prathap C. Reddy, founder-chairman, Apollo Hospitals Group, ex- pands the group’s integrat- ed healthcare ecosystem from its Greams Road cam- pus. Speaking at the inaugu- ration, Karen Sternfeld, a multiple sclerosis patient and Team USA para-arch- er, shared her experience of receiving therapy at Apollo AyurVAID.
Hyderabad : Apollo AyurVAID Hospitals, an Apollo Hospitals Group Company, India’s biggest network of precision Ayurveda hospitals, today announced its entry into Telangana with the launch of the “AyurVAID HCAH Centre for Precision Ayurveda and Integrative Medicine” in partnership with HCAH SuVitas, India’s largest network of single specialty recovery hospitals chain, at Somajiguda, Hyderabad.
The centre specializes in integrative rehabilitation and recovery for patients with complex, chronic, and degenerative conditions. Designed as a multidisciplinary centre of excellence, AyurVAID HCAH offers specialized and personalised treatment across Neurology and Neurodegenerative Disorders, Musculoskeletal Disorders- in particular patients suffering from traumatic brain injury, cerebrovascular accident/stroke, motor-neuron disease, in addition to patients post total-knee replacement or hip-replacement surgery, among others. Often the patients have a complex metabolic, inflammatory, immune-response health status with compromised cardiac, respiratory, kidney function compounded by non-healing wounds, bed-sores, etc. In addition, they have severe functional, quality-of-life deficits across sleep, appetite, bowels, micturition, anxiety-depression, vitality and energy levels. In particular, focus shall be on paediatric developmental disorders and geriatric care- at two ends of the age spectrum.
Apollo AyurVAID to expand pan India in FY26 By the end of FY26, the company aims to expand its network to 18 hospitals, and 1 clinic The bed strength will nearly double from the current 185 to 350 in this year It is aiming to reach 1,000 beds by 2028
AyurVAID on Wednesday announced its foray into the Ayurveda product segment with a capital outlay of Rs 15 crore, which will help the company cross Rs 500 crore revenue in the next five years.
This foray into the new vertical not only complements the inpatient-outpatient care model but also opens scalable revenue opportunities and reinforces the vision of mainstreaming evidence-based Ayurveda services and products by making it accessible globally, Apollo AyurVAID founder, MD and CEO Rajiv Vasudevan said in a statement.
Apollo AyurVAID, one of the largest Ayurvedic hospital chains in India, aims to have 1,000 beds across the country by 2028, as it sees demand for Ayurvedic treatment rising. The chain, which currently operates 12 hospitals and had 185 beds in operation by the end of FY25, handles around 40,000-42,000 patients annually. It is targeting 200,000 patients annually in the next five years, by which time the hospital chain aims to reach a *500 crore turnover.
Apollo AyurVAID, one of the largest Ayurvedic hospital chains in India, aims to have 1,000 beds across the country by 2028, as it sees demand for Ayurvedic treatment rising.
Avesthagen Limited and Apollo AyurVAID Announce Strategic Partnership- To Develop and Market “AvestaAyurVAID” Scientifically
Validated Medical Foods and Dietary Supplements. The products will be marketed under AvestaAyurVAID brand
AyurVAID, an integrative Ayurveda centre of excellence, has been set up at Apollo Hospitals’ Vanagaram campus
AyurVAID Hospitals Domlur, Bengaluru, set another historic milestone on May 20, on May 20, 2023, by becoming the 1st & only Ayurveda hospital to be accredited by the “Quality and Accreditation Institute (QAI), Centre for Accreditation of Health & Social Care” under the Transition Care Centre (TCC) Standard. QAI is India’s first and only accreditation organization to provide Transition Care Centre (TCC) certification for healthcare.
Insurance Regulatory and Development Authority of India (IRDAI) instructs insurers to provide equal coverage for AYUSH treatments. AYUSH includes Ayurveda, Yoga, Unani, Siddha, and Homeopathy therapies. Insurers must establish policies, modify products, and ensure quality standards for AYUSH coverage.
The conclave highlighted measures for positioning AYUSH products in global marketplace, demand generation and future scope. It also witnessed discussions on the role of AYUSH in achieving universal health coverage, the entrepreneurship ecosystem of the sector and modern-day perspective on AYUSH.
The Insurance Regulatory and Development Authority of India (IRDAI) asked general insurance companies to have board-approved policy guidelines for AYUSH coverage and give policyholders an option to choose a treatment of their choice. The guidelines will be effective from April 1, 2024.
The conclave highlighted measures for positioning AYUSH products in global marketplace, demand generation and future scope. It also witnessed discussions on the role of AYUSH in achieving universal health coverage, the entrepreneurship ecosystem of the sector and modern-day perspective on AYUSH.
Dementia India Alliance (DIA), a national, NGO dedicated to promoting awareness, advocacy, and care for people living with dementia, and Apollo AyurVAID Hospitals, India’s leading Precision Ayurveda hospital network under the Apollo Hospitals Group, have joined hands to advance integrative dementia care and awareness in India.
The collaboration aims to address the growing public health challenge posed by dementia by combining DIA’s expertise in care, community engagement and advocacy with Apollo AyurVAID’s clinical leadership in precision Ayurveda and integrative medicine. Together, the two organisations will work towards creating awareness that encourages timely medical help, facilitates early diagnosis, and better management of the condition.
With India’s elderly population expected to reach 319 million by 2050, accounting for one-fifth of the total population, the country faces a mounting public health challenge. According to industry estimates, about 7.4 per cent of Indians aged 60 and above are affected by dementia which is nearly 88 lakh people today – a number projected to rise to 1.7 crore by 2036.
Early and accurate diagnosis is the cornerstone of effective care, yet nearly 90 per cent of those living with dementia in India remain undiagnosed due to the limited availability of memory clinics, a critical gap that must be bridged to enable timely intervention and support. The increasing prevalence of risk factors associated with dementia — such as diabetes, hypertension, and more than 14 other modifiable factors — underscores the urgent need for proactive risk reduction and early intervention strategies.
Mumbai, 10 November 2025: Dementia India Alliance (DIA), a national, NGO dedicated to promoting awareness, advocacy, and care for people living with dementia, and Apollo AyurVAID Hospitals, India’s leading Precision Ayurveda hospital network under the Apollo Hospitals Group, have joined hands to advance integrative dementia care and awareness in India. The collaboration aims to address the growing public health challenge posed by dementia by combining DIA’s expertise in care, community engagement and advocacy with Apollo AyurVAID’s clinical leadership in precision Ayurveda and integrative medicine. Together, the two organizations will work towards creating awareness that encourages timely medical help, facilitates early diagnosis, and better management of the condition.
With India’s elderly population expected to reach 319 million by 2050, accounting for one-fifth of the total population, the country faces a mounting public health challenge. According to industry estimates, about 7.4 per cent of Indians aged 60 and above are affected by dementia which is nearly 88 lakh people today – a number projected to rise to 1.7 Crore by 2036. Early and accurate diagnosis is the cornerstone of effective care, yet nearly 90 per cent of those living with dementia in India remain undiagnosed due to the limited availability of memory clinics, a critical gap that must be bridged to enable timely intervention and support. The increasing prevalence of risk factors associated with dementia — such as diabetes, hypertension, and more than 14 other modifiable factors — underscores the urgent need for proactive risk reduction and early intervention strategies… In this context, the MoU between Dementia India Alliance and Apollo AyurVAID Hospitals marks a crucial step forward integrating evidence-based Ayurveda protocols with sustained community advocacy to advance early detection, prevention, and holistic management of dementia in India’s ageing population.
Apollo Hospitals’ Ayurveda arm, AyurVaid, is set for major expansion with plans to open four new hospitals within the next three months. This move will increase its network to 16 hospitals with over 350 beds, reflecting the growing interest in Ayurveda, especially among younger patients, according to a senior company executive.
Healthcare major Apollo Hospitals is planning to add four new facilities to its precision ayurveda healthcare arm, Apollo AyurVAID Hospitals, expanding the network to 350 beds over the next three to four months. The move comes as the group bets on the country’s growing demand for ayurveda-based in-patient and out-patient care.
Apollo AyurVAID Hospitals on Monday opened a 35-bed facility in Chennai. “We will not stop with one or two centres. We are trying to create a network that is fully integrated with the Apollo ecosystem. It will also be open to any healthcare provider that meets our standards of quality and care,” said Preetha Reddy, executive vice chairperson, Apollo Hospitals Enterprise, and chairperson, Apollo AyurVAID.
Apollo AyurVAID Hospi- tals, the Apollo Hospitals Group’s chain of precision Ayurveda hospitals, inaug- urated its flagship 35-bed facility on Greams Road on Monday. The centre, which was inaugurated by Prathap C. Reddy, founder-chairman, Apollo Hospitals Group, ex- pands the group’s integrat- ed healthcare ecosystem from its Greams Road cam- pus. Speaking at the inaugu- ration, Karen Sternfeld, a multiple sclerosis patient and Team USA para-arch- er, shared her experience of receiving therapy at Apollo AyurVAID.
Hyderabad : Apollo AyurVAID Hospitals, an Apollo Hospitals Group Company, India’s biggest network of precision Ayurveda hospitals, today announced its entry into Telangana with the launch of the “AyurVAID HCAH Centre for Precision Ayurveda and Integrative Medicine” in partnership with HCAH SuVitas, India’s largest network of single specialty recovery hospitals chain, at Somajiguda, Hyderabad.
The centre specializes in integrative rehabilitation and recovery for patients with complex, chronic, and degenerative conditions. Designed as a multidisciplinary centre of excellence, AyurVAID HCAH offers specialized and personalised treatment across Neurology and Neurodegenerative Disorders, Musculoskeletal Disorders- in particular patients suffering from traumatic brain injury, cerebrovascular accident/stroke, motor-neuron disease, in addition to patients post total-knee replacement or hip-replacement surgery, among others. Often the patients have a complex metabolic, inflammatory, immune-response health status with compromised cardiac, respiratory, kidney function compounded by non-healing wounds, bed-sores, etc. In addition, they have severe functional, quality-of-life deficits across sleep, appetite, bowels, micturition, anxiety-depression, vitality and energy levels. In particular, focus shall be on paediatric developmental disorders and geriatric care- at two ends of the age spectrum.
ఖచ్చితత్వం, సమగ్రతతో కూడిన ఆయుర్వేద చికిత్స అందించేందుకు అపోలో AyurVAID హాస్పిటల్స్ తెలంగాణలోకి ప్రవేశించింది. భారతదేశంలోనే అతిపెద్ద రికవరీ హాస్పిటల్స్ చైన్ అయిన HCAH సువిటాస్తో భాగస్వామ్యం కుదుర్చుకుంది. హైదరాబాద్లోని సోమాజిగూడలో తమ తొలి “AyurVAID HCAH సెంటర్ ఫర్ ప్రెసిషన్ ఆయుర్వేద అండ్ ఇంటిగ్రేటివ్ మెడిసిన్” ను ప్రారంభించినట్లు కంపెనీ మంగళవారం ప్రకటించింది. ఈ కేంద్రం ముఖ్యంగా ఇంటిగ్రేటివ్ న్యూరో రిహాబిలిటేటివ్ కేర్లో నిపుణత చూపిస్తుంది. సంక్లిష్ట, దీర్ఘకాలిక, క్షీణించిన అనారోగ్యాలతో బాధపడే రోగులకు సమగ్ర రీహాబిలిటేషన్, రికవరీ సేవలు అందిస్తుంది.
AyurVAID on Wednesday announced its foray into the Ayurveda product segment with a capital outlay of Rs 15 crore, which will help the company cross Rs 500 crore revenue in the next five years.
This foray into the new vertical not only complements the inpatient-outpatient care model but also opens scalable revenue opportunities and reinforces the vision of mainstreaming evidence-based Ayurveda services and products by making it accessible globally, Apollo AyurVAID founder, MD and CEO Rajiv Vasudevan said in a statement.
Apollo AyurVAID, one of the largest Ayurvedic hospital chains in India, aims to have 1,000 beds across the country by 2028, as it sees demand for Ayurvedic treatment rising. The chain, which currently operates 12 hospitals and had 185 beds in operation by the end of FY25, handles around 40,000-42,000 patients annually. It is targeting 200,000 patients annually in the next five years, by which time the hospital chain aims to reach a *500 crore turnover.
Insurance Regulatory and Development Authority of India (IRDAI) instructs insurers to provide equal coverage for AYUSH treatments. AYUSH includes Ayurveda, Yoga, Unani, Siddha, and Homeopathy therapies. Insurers must establish policies, modify products, and ensure quality standards for AYUSH coverage.
The conclave highlighted measures for positioning AYUSH products in global marketplace, demand generation and future scope. It also witnessed discussions on the role of AYUSH in achieving universal health coverage, the entrepreneurship ecosystem of the sector and modern-day perspective on AYUSH.
The Insurance Regulatory and Development Authority of India (IRDAI) asked general insurance companies to have board-approved policy guidelines for AYUSH coverage and give policyholders an option to choose a treatment of their choice. The guidelines will be effective from April 1, 2024.
The conclave highlighted measures for positioning AYUSH products in global marketplace, demand generation and future scope. It also witnessed discussions on the role of AYUSH in achieving universal health coverage, the entrepreneurship ecosystem of the sector and modern-day perspective on AYUSH.
Healthcare major Apollo Hospitals is planning to add four new facilities to its precision ayurveda healthcare arm, Apollo AyurVAID Hospitals, expanding the network to 350 beds over the next three to four months. The move comes as the group bets on the country’s growing demand for ayurveda-based in-patient and out-patient care.
Apollo AyurVAID Hospitals on Monday opened a 35-bed facility in Chennai. “We will not stop with one or two centres. We are trying to create a network that is fully integrated with the Apollo ecosystem. It will also be open to any healthcare provider that meets our standards of quality and care,” said Preetha Reddy, executive vice chairperson, Apollo Hospitals Enterprise, and chairperson, Apollo AyurVAID.
Apollo AyurVAID Hospi- tals, the Apollo Hospitals Group’s chain of precision Ayurveda hospitals, inaug- urated its flagship 35-bed facility on Greams Road on Monday. The centre, which was inaugurated by Prathap C. Reddy, founder-chairman, Apollo Hospitals Group, ex- pands the group’s integrat- ed healthcare ecosystem from its Greams Road cam- pus. Speaking at the inaugu- ration, Karen Sternfeld, a multiple sclerosis patient and Team USA para-arch- er, shared her experience of receiving therapy at Apollo AyurVAID.
AyurVAID, an integrative Ayurveda centre of excellence, has been set up at Apollo Hospitals’ Vanagaram campus
AyurVAID Hospitals Domlur, Bengaluru, set another historic milestone on May 20, on May 20, 2023, by becoming the 1st & only Ayurveda hospital to be accredited by the “Quality and Accreditation Institute (QAI), Centre for Accreditation of Health & Social Care” under the Transition Care Centre (TCC) Standard. QAI is India’s first and only accreditation organization to provide Transition Care Centre (TCC) certification for healthcare.
Hours of Operation:
8am – 8pm (Mon-Sat)
8am – 5pm (Sun)
